LIBRE (Ligamys, Internal Bracing, REconstruction) Study: Comparing Three Surgery Techniques After an Acute ACL Rupture.
LIBRE
Single-blind, Multi-centre, Randomized Controlled Trial Comparing Ligamys Anterior Cruciate Ligament (ACL) Repair, Internal Bracing ACL Repair and Conventional ACL Reconstruction for Relative Clinical Efficacy and Economic Benefit.
2 other identifiers
interventional
95
1 country
3
Brief Summary
Single-blind, multi-centre, prospective, randomized controlled trial comparing Ligamys Anterior Cruciate Ligament (ACL) repair, Internal Bracing ACL repair and conventional ACL reconstruction for relative clinical efficacy and economic benefit. Patients with a primary proximal acute ACL rupture will be included in either study 1 (0-4 weeks post rupture) or study 2 (5-12 weeks post rupture) of the LIBRE study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2018
CompletedStudy Start
First participant enrolled
February 15, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedMay 16, 2024
May 1, 2024
5.9 years
February 13, 2018
May 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
International Knee Documentation Committee (IKDC) Score
The International Knee Documentation Committee (IKDC) is a commonly used instrument to determine the outcome following various knee procedures, including ACL reconstructions. In essence, it is a subjective well-known tool that provides patients with an overall function score (range between 0 to 100). The score is interpreted as a measure of function with higher scores representing higher levels of function. The questionnaire addresses 3 categories: symptoms (i.e. pain, swelling, stiffness etc.), activity (rising from chair, going up and down stairs, jumping, squatting etc.) and knee function. The knee function studies focus primarily on one question: "How is the knee function post-operative compared to the situation before the injury?". In conclusion, the IKDC score is a reliable, well established and both patient and clinician friendly tool (i.e. it is easy and it requires little time to complete).
Baseline (pre-rupture), week 13, week 26, week 52, week 104. At 6 months follow-up the primary outcome will be measured, a change of 13 IKDC points between the treatments is considered clinically meaningful.
Secondary Outcomes (9)
Failure (re-rupture/instability complaints)
Day 1, week 2, week 6, week 13, week 26, week 52, week 104.
Tegner score
Baseline (pre-rupture), week 13, week 26, week 52, week 104.
Lysholm score
Baseline (pre-rupture), week 13 post-operative, week 26 post-operative, week 52 post-operative, week 104 post-operative
EQ-5D-5L
Baseline (pre-operative), day 1, week 2, week 6, week 13, week 26, week 52, week 104.
Return to work/sport
Day 1, week 2, week 6, week 13, week 26, week 52, week 104.
- +4 more secondary outcomes
Study Arms (4)
Study 1 Ligamys
EXPERIMENTALRepair Surgery.
Study 1 Internal Bracing
EXPERIMENTALRepair Surgery.
Study 2 Internal Bracing
EXPERIMENTALRepair Surgery.
Study 2 Reconstruction
ACTIVE COMPARATORReconstructive Surgery.
Interventions
Eligibility Criteria
You may qualify if:
- Primary acute proximal ACL rupture (MRI and per-operative confirmation): 3-digit ACL rupture classification, type A (supplement 1)
- Between 18-50 years, male or female
- Randomization and surgery within 4 weeks after the ACL rupture (Study 1)
- Randomization and surgery between 5-12 weeks after the ACL rupture (Study 2)
- The ACL remnant is suitable for repair in the three treatment groups: the distal ACL remnant must be in contact with the proximal remnant/femoral condyle for at least 75% (per-operative confirmation)
- The patient is mentally and verbally capable of participating in the study.
- Written informed consent (according to the International Conference on Harmonisation (ICH)-GCP Guidelines).
You may not qualify if:
- Known posterior cruciate ligament (PCL) and/or posterolateral ligamentous complex (PLC), lateral collateral ligament (LCL) or medial collateral ligament (MCL) grade 3 injury.
- Known osseous fractures that could impair revalidation and/or ACL repair
- Patients with neurological disorders or systemic diseases
- Patients with trauma/fractures in the lower limb in the past 6 months that could influence rehabilitation
- Non-sportive patients with a Tegner score of \<3: these patients could probably counteract instability complaints with intensive physiotherapy.
- Any inflammatory disease, Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), active malignancy
- Patient not suited for intervention due to lack of mobility, meaning not achieving 90° of flexion before surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Antwerplead
- Universitair Ziekenhuis Brusselcollaborator
- Onze Lieve Vrouw Hospitalcollaborator
Study Sites (3)
University Hospital, Antwerp
Edegem, Antwerp, 2650, Belgium
University Hospital, Brussels
Jette, Brussels Capital, 1090, Belgium
OLV Hospital
Aalst, Oost-Vlaanderen, 9300, Belgium
Related Publications (1)
Heusdens CHW, Zazulia K, Roelant E, Dossche L, van Tiggelen D, Roeykens J, Smits E, Vanlauwe J, Van Dyck P. Study protocol: a single-blind, multi-center, randomized controlled trial comparing dynamic intraligamentary stabilization, internal brace ligament augmentation and reconstruction in individuals with an acute anterior cruciate ligament rupture: LIBRƎ study. BMC Musculoskelet Disord. 2019 Nov 18;20(1):547. doi: 10.1186/s12891-019-2926-0.
PMID: 31739784DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christiaan Heusdens
UH, Antwerp
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Also the treating physiotherapist is blinded to the treatment the participant received.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
February 13, 2018
First Posted
February 22, 2018
Study Start
February 15, 2018
Primary Completion
January 15, 2024
Study Completion
August 30, 2025
Last Updated
May 16, 2024
Record last verified: 2024-05